|
Apr 25
|
Top 5 Nasdaq-Listed, Non-Tech Stocks Set to Beat on Q1 Earnings
|
|
Apr 24
|
IPO Edge Bootcamp at Nasdaq May 6 with Stifel, ICR, Goodmans, KPMG, Gallagher, Vinson & Elkins, CFGI
|
|
Apr 23
|
Oil Rises as Risk-On Mood Counters Waning Geopolitical Concerns
|
|
Apr 22
|
Carlyle-Backed Crescent Midstream Explores Sale
|
|
Apr 22
|
What Makes Carlyle (CG) a New Buy Stock
|
|
Apr 22
|
What Makes Carlyle Secured Lending (CGBD) a New Buy Stock
|
|
Apr 19
|
There’s an early winner in the race to feed AI’s infrastructure demands: Private equity
|
|
Apr 18
|
Acentra Health Slashes Interest Rate in Private Debt Refinancing
|
|
Apr 15
|
Carlyle Group (CG) is a Top Dividend Stock Right Now: Should You Buy?
|
|
Apr 15
|
How CVC Would Stack Up Against Other Publicly Traded Buyout Firms
|
|
Apr 14
|
Carlyle Picks JPMorgan and Kotak to Help Arrange Hexaware IPO, Sources Say
|
|
Apr 11
|
Carlyle Secured Lending, Inc. Schedules Earnings Release and Quarterly Earnings Call to Discuss its First Quarter Ended March 31, 2024 Financial Results
|
|
Apr 5
|
New Era for Pay Catapults Carlyle’s CEO Past Old Goldman Rival
|
|
Apr 4
|
Exclusive-Carlyle mulls $10 billion sale of StandardAero, sources say
|
|
Apr 4
|
Boss of Southend Airport private equity owner handed $187m pay package
|
|
Apr 3
|
Carlyle CEO Awarded $187 Million Pay Package in First Year
|
|
Apr 1
|
Clinical Collaboration Agreement between Teva and Launch Therapeutics to Accelerate Development of Dual-Action Asthma Rescue Inhaler (ICS-SABA/TEV-’248) Respiratory Program; Teva and Abingworth Enter Strategic Development Funding Agreement
|
|
Mar 29
|
This is Why Carlyle Group (CG) is a Great Dividend Stock
|
|
Mar 28
|
A-Rod, Marc Lore Won’t Buy Controlling Stake in NBA’s Timberwolves
|
|
Mar 28
|
Harvey Schwartz Spends First Year at Carlyle Tending Old Wounds
|